Phase Genomics
Phase Genomics Wins $5.5M in NIH, Gates Foundation Grants for Therapeutic Phage Discovery
The company will use its proximity-guided metagenomics platform to build an atlas of phage-bacteria interactions and identify phages that could be used therapeutically.
Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development
The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.
Qiagen, Phase Genomics Ink US Licensing Agreement for Hi-C Sequencing Technology
Qiagen can now sell Phase's proprietary proximity-ligation technology for chromatin conformational analysis research in the US.
NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics
The Seattle-based firm has won two grants each worth $1.9 million to develop proximity ligation assays with applications in cytogenetics.